Patents by Inventor Beau Mainous

Beau Mainous has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME
    Publication number: 20230233638
    Abstract: Cosmetic and dietary supplement compositions containing silymarin and sulfoalkyl ether cyclodextrin, particularly sulfobutyl ether cyclodextrin, are described. The compositions and methods are useful in reducing appearance of facial redness in rosacea-prone skin, rejuvenating skin, preventing skin aging, inhibiting oxidative stress in epidermal and dermal cells, increasing collagen production, reducing the likelihood of skin cancer, treating or reducing liver damage from a toxin, or treating a liver disease.
    Type: Application
    Filed: June 29, 2022
    Publication date: July 27, 2023
    Inventors: James D. Pipkin, Roger A. Rajewski, Beau Mainous
  • Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
    Patent number: 11382944
    Abstract: Cosmetic and dietary supplement compositions containing silymarin and sulfoalkyl ether cyclodextrin, particularly sulfobutyl ether cyclodextrin, are described. The compositions and methods are useful in reducing appearance of facial redness in rosacea-prone skin, rejuvenating skin, preventing skin aging, inhibiting oxidative stress in epidermal and dermal cells, increasing collagen production, reducing the likelihood of skin cancer, treating or reducing liver damage from a toxin, or treating a liver disease.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: July 12, 2022
    Assignees: CyDex Pharmaceuticals, Inc., University of Kansas
    Inventors: James D. Pipkin, Roger A. Rajewski, Beau Mainous
  • COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME
    Publication number: 20200330539
    Abstract: Cosmetic and dietary supplement compositions containing silymarin and sulfoalkyl ether cyclodextrin, particularly sulfobutyl ether cyclodextrin, are described. The compositions and methods are useful in reducing appearance of facial redness in rosacea-prone skin, rejuvenating skin, preventing skin aging, inhibiting oxidative stress in epidermal and dermal cells, increasing collagen production, reducing the likelihood of skin cancer, treating or reducing liver damage from a toxin, or treating a liver disease.
    Type: Application
    Filed: July 2, 2020
    Publication date: October 22, 2020
    Inventors: James D. Pipkin, Roger A. Rajewski, Beau Mainous
  • Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
    Patent number: 10702568
    Abstract: Cosmetic and dietary supplement compositions containing silymarin and sulfoalkyl ether cyclodextrin, particularly sulfobutyl ether cyclodextrin, are described. The compositions and methods are useful in reducing appearance of facial redness in rosacea-prone skin, rejuvenating skin, preventing skin aging, inhibiting oxidative stress in epidermal and dermal cells, increasing collagen production, reducing the likelihood of skin cancer, treating or reducing liver damage from a toxin, or treating a liver disease.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: July 7, 2020
    Assignees: CyDex Pharmaceuticals, Inc., University of Kansas
    Inventors: James D. Pipkin, Roger A. Rajewski, Beau Mainous
  • COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME
    Publication number: 20180133274
    Abstract: Cosmetic and dietary supplement compositions containing silymarin and sulfoalkyl ether cyclodextrin, particularly sulfobutyl ether cyclodextrin, are described. The compositions and methods are useful in reducing appearance of facial redness in rosacea-prone skin, rejuvenating skin, preventing skin aging, inhibiting oxidative stress in epidermal and dermal cells, increasing collagen production, reducing the likelihood of skin cancer, treating or reducing liver damage from a toxin, or treating a liver disease.
    Type: Application
    Filed: March 18, 2016
    Publication date: May 17, 2018
    Inventors: James D. Pipkin, Roger A. Rajewski, Beau Mainous